These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19628)

  • 1. An approach to peripheral vasodilator-beta-adrenergic blocking agents.
    Baldwin JJ; Hirschmann R; Lumma PK; Lumma WC; Ponticello GS; Sweet CS; Scriabine A
    J Med Chem; 1977 Aug; 20(8):1024-9. PubMed ID: 19628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. beta-Adrenergic blocking agents with acute antihypertensive activity.
    Baldwin JJ; Engelhardt EL; Hirschmann R; Lundell GF; Ponticello GS; Ludden CT; Sweet CS; Scriabine A; Share NN; Hall R
    J Med Chem; 1979 Jun; 22(6):687-94. PubMed ID: 37337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symbiotic approach to drug design: antihypertensive beta-adrenergic blocking agents.
    Baldwin JJ; Lumma WC; Lundell GF; Ponticello GS; Raab AW; Engelhardt EL; Hirschmann R; Sweet CS; Scriabine A
    J Med Chem; 1979 Nov; 22(11):1284-90. PubMed ID: 42797
    [No Abstract]   [Full Text] [Related]  

  • 4. Heterocyclic analogues of the antihypertensive beta-adrenergic blocking agent (S)-2-[3-(ter-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
    Baldwin JJ; Engelhardt EL; Hirschmann R; Ponticello GS; Atkinson JG; Wasson BK; Sweet CS; Scriabine A
    J Med Chem; 1980 Jan; 23(1):65-70. PubMed ID: 6102151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive indole derivatives of phenoxypropanolamines with beta-adrenergic receptor antagonist and vasodilating activity.
    Kreighbaum WE; Matier WL; Dennis RD; Minielli JL; Deitchman D; Perhach JL; Comer WT
    J Med Chem; 1980 Mar; 23(3):285-9. PubMed ID: 6102605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to vasodilating/beta-adrenergic blocking agents: examples of the dihydrolutidine type.
    Baldwin JJ; Hirschmann R; Engelhardt EL; Ponticello GS; Sweet CS; Scriabine A
    J Med Chem; 1981 May; 24(5):628-31. PubMed ID: 6113285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on new beta-adrenergic blocking agents. II. Syntheses and pharmacology of 2-anilinotropone derivatives.
    Sato Y; Tanaka T; Kumakura S; Koike H; Oshima T
    Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):514-22. PubMed ID: 4153810
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on agents with vasodilator and beta-blocking activities. I.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on agents with vasodilator and beta-blocking activities. IV.
    Seki T; Nakao T; Masuda T; Hasumi K; Gotanda K; Ishimori T; Honma S; Minami N; Shibata K; Yasuda K
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2061-9. PubMed ID: 8945771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on agents with vasodilator and beta-blocking activities. III. Synthesis and activity of optical isomers of TZC-1370.
    Seki T; Takezaki T; Ohuchi R; Saitoh M; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1719-23. PubMed ID: 8536346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of a series of combined vasodilator/beta-adrenoceptor antagonists based on 6-arylpyridazinones.
    Slater RA; Howson W; Swayne GT; Taylor EM; Reavill DR
    J Med Chem; 1988 Feb; 31(2):345-51. PubMed ID: 2892934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on agents with vasodilator and beta-blocking activities. II.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Tanimoto Y; Yamaguchi T; Saitoh M; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):247-55. PubMed ID: 7728931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on agents with vasodilator and beta-blocking activities. V. Synthesis and pharmacological activity of the optical isomers of TZC-5665.
    Seki T; Kanada A; Nakao T; Shiraiwa M; Asano H; Miyazawa K; Ishimori T; Minami N; Shibata K; Yasuda K
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):84-96. PubMed ID: 9468640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antiarrhythmic activity of new 1-[1-[2-[3-(alkylamino)-2-hydroxypropoxy]phenyl]vinyl]-1 H-imidazoles and related compounds.
    Ogata M; Matsumoto H; Takahashi K; Shimizu S; Kida S; Ueda M; Kimoto S; Haruna M
    J Med Chem; 1984 Sep; 27(9):1142-9. PubMed ID: 6147415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activity of the four stereoisomers of 6-[4-[3-[[2-hydroxy-3-[4-[2- (cyclopropylmethoxy)ethyl]phenoxy]propyl]amino]-propionamido] phenyl]-5-methyl-4,5-dihydro-3(2H)-pyridazinone, a combined vasodilator and beta-adrenoceptor antagonist.
    Howson W; Kitteringham J; Mistry J; Mitchell MB; Novelli R; Slater RA; Swayne GT
    J Med Chem; 1988 Feb; 31(2):352-6. PubMed ID: 2892935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta 1-selective adrenoceptor antagonists: examples of the 2-[4-[3-(substituted amino)-2-hydroxypropoxy]phenyl]imidazole class. 2.
    Baldwin JJ; Christy ME; Denny GH; Habecker CN; Freedman MB; Lyle PA; Ponticello GS; Varga SL; Gross DM; Sweet CS
    J Med Chem; 1986 Jun; 29(6):1065-80. PubMed ID: 2872332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on cardiovascular agents. 6. Synthesis and coronary vasodilating and antihypertensive activities of 1,2,4-triazolo[1,5-a]pyrimidines fused to heterocyclic systems.
    Sato Y; Shimoji Y; Fujita H; Nishino H; Mizuno H; Kobayashi S; Kumakura S
    J Med Chem; 1980 Aug; 23(8):927-37. PubMed ID: 7401118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and vasorelaxing activities of synthetic xanthone derivatives.
    Wang LW; Kang JJ; Chen IJ; Teng CM; Lin CN
    Bioorg Med Chem; 2002 Mar; 10(3):567-72. PubMed ID: 11814844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive beta-adrenergic blocking agents: N-aralkyl analogues of 2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridine.
    McClure DE; Baldwin JJ; Randall WC; Lyon TF; Mensler K; Lundell GF; Raab AW; Gross D; Risley EA; Sweet CS; Williams M
    J Med Chem; 1983 May; 26(5):649-57. PubMed ID: 6132999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and ocular antihypertensive activity of new imidazolidine derivatives containing a beta-blocking side chain.
    Huber D; Ehrhardt JD; Decker N; Himber J; Andermann G; Leclerc G
    J Med Chem; 1991 Nov; 34(11):3197-204. PubMed ID: 1956038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.